Position in ABBV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$107,223,004
-$9,119,305 QoQ
Shares Held
493,002
-3.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $107,223,004 | 493,002 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $116,342,309 | 509,179 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $120,930,563 | 522,288 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,530,808 | 530,820 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,078,182 | 491,973 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $89,128,278 | 501,566 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $97,606,662 | 494,261 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $86,897,349 | 506,631 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $88,567,977 | 486,370 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $77,689,715 | 501,321 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $76,038,785 | 510,122 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $70,243,371 | 521,364 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $83,981,296 | 526,958 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $86,017,892 | 532,256 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $72,836,974 | 542,709 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $84,009,178 | 548,506 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $90,803,160 | 560,133 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $52,887,104 | 390,599 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $43,054,692 | 399,135 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $46,124,953 | 409,490 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $45,772,081 | 422,954 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $45,940,991 | 428,754 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $39,193,196 | 447,462 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $45,252,929 | 460,918 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $29,042,485 | 381,185 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||